Factors That Influence Response to ASHAP
| . | CR . | PR . | Failure . | Chi Square for Independence . |
|---|---|---|---|---|
| Extranodal sites | ||||
| 0 | 12 | 7 | 7 | |
| 1 | 6 | 7 | 6 | 0.28 |
| ≥2 | 1 | 6 | 4 | |
| Response duration (months) to last treatment | ||||
| <12 | 10 | 14 | 9 | |
| ≥12 | 9 | 6 | 8 | 0.45 |
| <6 | 8 | 10 | 14 | |
| ≥6 | 11 | 10 | 3 | 0.01 |
| Radiotherapy | ||||
| Yes | 8 | 9 | 12 | |
| No | 11 | 11 | 5 | 0.09 |
| Stage at relapse | ||||
| Localized | 7 | 6 | 6 | 0.72 |
| Disseminated | 12 | 14 | 11 | |
| B symptoms | ||||
| No | 15 | 12 | 8 | |
| Yes | 4 | 8 | 9 | 0.04 |
| . | CR . | PR . | Failure . | Chi Square for Independence . |
|---|---|---|---|---|
| Extranodal sites | ||||
| 0 | 12 | 7 | 7 | |
| 1 | 6 | 7 | 6 | 0.28 |
| ≥2 | 1 | 6 | 4 | |
| Response duration (months) to last treatment | ||||
| <12 | 10 | 14 | 9 | |
| ≥12 | 9 | 6 | 8 | 0.45 |
| <6 | 8 | 10 | 14 | |
| ≥6 | 11 | 10 | 3 | 0.01 |
| Radiotherapy | ||||
| Yes | 8 | 9 | 12 | |
| No | 11 | 11 | 5 | 0.09 |
| Stage at relapse | ||||
| Localized | 7 | 6 | 6 | 0.72 |
| Disseminated | 12 | 14 | 11 | |
| B symptoms | ||||
| No | 15 | 12 | 8 | |
| Yes | 4 | 8 | 9 | 0.04 |